Danish study concluded that: fertility drugs does not increase breast cancer risk

Danish scholars in a study showed increased risk of fertility drugs and breast cancer has nothing to do.
ohio mesothelioma attorney air ambulance specialists orange county personal injury attorney

Danish Cancer Society, Jensen and his colleagues evaluated several types of fertility drugs on breast cancer risk of the different effects include the study of more than 5.4 million women who have fertility problems, after adjusting for the factors of pregnancy once again conducted a cohort study.

The most commonly used fertility drugs, including clomiphene citrate and human chorionic gonadotropin (hCG), a small number of women's access to follicle-stimulating hormone (FSH), human menopausal gonadotropin (hMG), gonadotropin-releasing hormone (GnRH ), and lutein.

The results showed that in into the group after a median time of 14.2 years, 331 cases of breast cancer occurred in women. The births and breast cancer risk significantly lower correlation. After adjusting for birth through the production number and additional numbers, the researchers found that clomiphene citrate, hCG, GnRH, FSH, and hMG on breast cancer risk had no significant effect. In addition, five kinds of the most frequently used fertility drugs may also be combined for breast cancer had no significant effect.

Jensen reported that the luteinizing hormone and then with an increased risk of breast cancer related, but based solely on the basis of 8 cases. That the use of fertility drugs the absolute risk of breast cancer is still low.